Certified Group Invests in Kaycha Labs' Knoxville Hemp & CBD Testing Laboratory
December 19, 2022
Certified Group, a PE-backed North American laboratory testing and regulatory consulting provider, announced an investment in the Knoxville, Tennessee hemp and CBD testing laboratory business of Kaycha Labs. The facility will operate under the Labstat name and expands Certified Group's hemp/CBD testing capabilities in the U.S., complementing its existing food, cosmetics and supplement testing services.
- Buyers
- Certified Group
- Targets
- Kaycha Labs (Knoxville, TN laboratory)
- Sellers
- Kaycha Labs
- Platforms
- Labstat
- Industry
- Professional Services
- Location
- Tennessee, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Kanbrick Acquires Laboratory Testing Inc.
April 22, 2025
Industrial Services
Kanbrick, a long-term investment partnership, has acquired Laboratory Testing Inc. (LTI), a Hatfield, Pennsylvania-based materials testing and calibration laboratory, in partnership with the McVaugh and Hiller families. Kanbrick will work with LTI’s leadership to expand capabilities, enter new markets, and accelerate growth across mission-critical end markets including aerospace, defense and power generation.
-
SC Labs Acquires C4 Laboratories
April 24, 2023
Healthcare Services
SC Labs, a leading U.S. cannabis and hemp testing company headquartered in Santa Cruz, California, has acquired C4 Laboratories of Scottsdale, Arizona. The acquisition expands SC Labs' licensed and accredited footprint to five states and adds C4's advanced cannabis testing capabilities to SC Labs' national testing and compliance platform.
-
Cannabinoid Biosciences Acquires CannabidiolHemp
November 25, 2019
Consumer Products
Cannabinoid Biosciences, Inc., a California-based biopharmaceutical subsidiary of Kid Castle, has acquired CannabidiolHemp (CannabidiolHemp.net), a CBD quality aggregator and validator. The purchase is the first of multiple planned acquisitions intended to build a vertically integrated CBD distribution and supply-chain business across the United States and Canada.
-
Capitala Group and Pike Street Capital Invest $19.5M in US BioTek Laboratories
January 8, 2019
Healthcare Services
Capitala Group, alongside Pike Street Capital, provided a $19.5 million financing package (senior secured debt and equity) to US BioTek Laboratories to support the company's next phase of growth. The capital will fund expansion of US BioTek's specialty immunology and allergy testing capabilities as well as sales and marketing initiatives.
-
Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products
January 12, 2021
Medical Devices
Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.
-
ACT Laboratories Acquires CDX Analytics
September 28, 2022
Healthcare Services
ACT Laboratories, Inc. has agreed to acquire CDX Analytics, LLC to expand its cannabis and hemp testing footprint into Massachusetts. ACT Labs — majority owned by Intrinsic Capital Partners — said the deal (subject to Massachusetts regulatory approval) will extend its multistate laboratory network and enhance capacity and scientific capabilities for local cultivators, processors and dispensaries.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.